Compare ARWR & MTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARWR | MTG |
|---|---|---|
| Founded | 2001 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 6.3B |
| IPO Year | 1993 | 1991 |
| Metric | ARWR | MTG |
|---|---|---|
| Price | $58.23 | $28.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | ★ $55.50 | $26.80 |
| AVG Volume (30 Days) | ★ 2.5M | 1.3M |
| Earning Date | 11-25-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | N/A | ★ 9.77 |
| EPS | N/A | ★ 3.11 |
| Revenue | $829,448,000.00 | ★ $1,216,428,000.00 |
| Revenue This Year | N/A | $2.34 |
| Revenue Next Year | N/A | $3.48 |
| P/E Ratio | ★ N/A | $9.12 |
| Revenue Growth | ★ 23258.15 | 2.20 |
| 52 Week Low | $9.57 | $21.94 |
| 52 Week High | $59.15 | $29.01 |
| Indicator | ARWR | MTG |
|---|---|---|
| Relative Strength Index (RSI) | 74.49 | 60.81 |
| Support Level | $37.06 | $28.19 |
| Resistance Level | $59.15 | $28.68 |
| Average True Range (ATR) | 3.92 | 0.41 |
| MACD | 1.64 | 0.04 |
| Stochastic Oscillator | 90.86 | 92.13 |
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection accounts for close to majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia and New York.